EE03873B1 - Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine - Google Patents

Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine

Info

Publication number: EE03873B1
Authority: EE; Estonia
Prior art keywords: alkyloxfuranone; preparation; compounds obtained; amine derivatives; amine
Prior art date: 1997-07-15

Application number

EEP200000024A

Other languages

English (en)

Estonian (et)

Inventor

Bouchet Rapha�l

Brion Francis

Colladant Colette

Lagouardat Jacques

Original Assignee

Hoechst Marion Roussel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-15

Filing date

1998-07-09

Publication date

2002-10-15

1998-07-09 Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel

2000-10-16 Publication of EE200000024A publication Critical patent/EE200000024A/xx

2002-10-15 Publication of EE03873B1 publication Critical patent/EE03873B1/xx

Links

150000001412 amines Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Furan Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

EEP200000024A 1997-07-15 1998-07-09 Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine EE03873B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9708932A FR2766188B1 (fr)	1997-07-15	1997-07-15	Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes
PCT/FR1998/001480 WO1999003852A1 (fr)	1997-07-15	1998-07-09	Procede de preparation de derives amines d'alkyloxyfuranone, composes issus de ce procede et utilisation de ces composes

Publications (2)

Publication Number	Publication Date
EE200000024A EE200000024A (et)	2000-10-16
EE03873B1 true EE03873B1 (et)	2002-10-15

Family

ID=9509210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200000024A EE03873B1 (et)	1997-07-15	1998-07-09	Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine

Country Status (34)

Country	Link
US (1)	US6235899B1 (de)
EP (1)	EP0998470B1 (de)
JP (1)	JP4450987B2 (de)
KR (1)	KR100519691B1 (de)
CN (1)	CN100363355C (de)
AP (1)	AP1071A (de)
AR (1)	AR015924A1 (de)
AT (1)	ATE239713T1 (de)
AU (1)	AU744272B2 (de)
BG (1)	BG64050B1 (de)
BR (1)	BR9810896A (de)
CA (1)	CA2296742C (de)
CZ (1)	CZ295312B6 (de)
DE (1)	DE69814395T2 (de)
DK (1)	DK0998470T3 (de)
EA (1)	EA002883B1 (de)
EE (1)	EE03873B1 (de)
ES (1)	ES2197489T3 (de)
FR (1)	FR2766188B1 (de)
HR (1)	HRP20000027B1 (de)
HU (1)	HU230148B1 (de)
ID (1)	ID23784A (de)
IL (1)	IL134031A (de)
ME (1)	ME01708B (de)
NO (1)	NO324508B1 (de)
NZ (1)	NZ502338A (de)
PL (1)	PL200820B1 (de)
PT (1)	PT998470E (de)
RS (1)	RS49832B (de)
SK (1)	SK284168B6 (de)
TR (1)	TR200000117T2 (de)
UA (1)	UA66364C2 (de)
WO (1)	WO1999003852A1 (de)
ZA (1)	ZA986203B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7053056B2 (en) *	1998-07-02	2006-05-30	Idun Pharmaceuticals, Inc.	C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
DE60142470D1 (de) *	2000-04-24	2010-08-12	Vertex Pharma	Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen
PE20011350A1 (es)	2000-05-19	2002-01-15	Vertex Pharma	PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
JP2003327568A (ja) *	2000-09-20	2003-11-19	Kanegafuchi Chem Ind Co Ltd	光学活性β−アミノ酸誘導体の製造方法
WO2002055478A1 (en) *	2001-01-16	2002-07-18	Kaneka Corporation	Process for preparation of optically active aminolactone derivatives and intermediates of the derivatives
EP1718639A2 (de)	2004-02-27	2006-11-08	Vertex Pharmaceuticals Incorporated	Caspaseinhibitoren und deren verwendungen
KR101135765B1 (ko) *	2004-03-12	2012-04-23	버텍스 파마슈티칼스 인코포레이티드	아스파르트산 아세탈 카스파아제 억제제의 제조를 위한방법 및 중간체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6204261B1 (en) *	1995-12-20	2001-03-20	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β Converting enzyme inhibitors
US5716929A (en) *	1994-06-17	1998-02-10	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1β converting enzyme

1997
- 1997-07-15 FR FR9708932A patent/FR2766188B1/fr not_active Expired - Lifetime
1998
- 1998-07-09 ID IDW20000067A patent/ID23784A/id unknown
- 1998-07-09 JP JP2000503076A patent/JP4450987B2/ja not_active Expired - Lifetime
- 1998-07-09 ES ES98937591T patent/ES2197489T3/es not_active Expired - Lifetime
- 1998-07-09 NZ NZ502338A patent/NZ502338A/en not_active IP Right Cessation
- 1998-07-09 AU AU86333/98A patent/AU744272B2/en not_active Expired
- 1998-07-09 HR HR20000027A patent/HRP20000027B1/xx not_active IP Right Cessation
- 1998-07-09 EE EEP200000024A patent/EE03873B1/xx unknown
- 1998-07-09 RS YUP-15/00A patent/RS49832B/sr unknown
- 1998-07-09 SK SK30-2000A patent/SK284168B6/sk not_active IP Right Cessation
- 1998-07-09 ME MEP-2000-15A patent/ME01708B/me unknown
- 1998-07-09 KR KR10-2000-7000398A patent/KR100519691B1/ko not_active Expired - Lifetime
- 1998-07-09 DE DE69814395T patent/DE69814395T2/de not_active Expired - Lifetime
- 1998-07-09 EA EA200000127A patent/EA002883B1/ru not_active IP Right Cessation
- 1998-07-09 EP EP98937591A patent/EP0998470B1/de not_active Expired - Lifetime
- 1998-07-09 TR TR2000/00117T patent/TR200000117T2/xx unknown
- 1998-07-09 PT PT98937591T patent/PT998470E/pt unknown
- 1998-07-09 IL IL13403198A patent/IL134031A/en not_active IP Right Cessation
- 1998-07-09 HU HU0003857A patent/HU230148B1/hu unknown
- 1998-07-09 US US09/463,014 patent/US6235899B1/en not_active Expired - Lifetime
- 1998-07-09 AT AT98937591T patent/ATE239713T1/de active
- 1998-07-09 CZ CZ200065A patent/CZ295312B6/cs not_active IP Right Cessation
- 1998-07-09 BR BR9810896-4A patent/BR9810896A/pt not_active Application Discontinuation
- 1998-07-09 CN CNB98808967XA patent/CN100363355C/zh not_active Expired - Lifetime
- 1998-07-09 AP APAP/P/2000/001732A patent/AP1071A/en active
- 1998-07-09 WO PCT/FR1998/001480 patent/WO1999003852A1/fr not_active Ceased
- 1998-07-09 PL PL338035A patent/PL200820B1/pl unknown
- 1998-07-09 CA CA002296742A patent/CA2296742C/fr not_active Expired - Lifetime
- 1998-07-09 DK DK98937591T patent/DK0998470T3/da active
- 1998-07-13 ZA ZA9806203A patent/ZA986203B/xx unknown
- 1998-07-15 AR ARP980103455A patent/AR015924A1/es not_active Application Discontinuation
- 1998-09-07 UA UA2000020800A patent/UA66364C2/uk unknown
2000
- 2000-01-12 BG BG104073A patent/BG64050B1/bg unknown
- 2000-01-14 NO NO20000182A patent/NO324508B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
US6235899B1 (en)	2001-05-22
HUP0003857A3 (en)	2002-08-28
CZ295312B6 (cs)	2005-07-13
KR20010021834A (ko)	2001-03-15
RS49832B (sr)	2008-08-07
CN100363355C (zh)	2008-01-23
PL338035A1 (en)	2000-09-25
HRP20000027A2 (en)	2000-10-31
AP2000001732A0 (en)	2000-03-31
PT998470E (pt)	2003-09-30
NO20000182L (no)	2000-03-07
ATE239713T1 (de)	2003-05-15
NZ502338A (en)	2001-09-28
AU8633398A (en)	1999-02-10
JP4450987B2 (ja)	2010-04-14
ES2197489T3 (es)	2004-01-01
CZ200065A3 (cs)	2000-07-12
DE69814395D1 (de)	2003-06-12
EE200000024A (et)	2000-10-16
PL200820B1 (pl)	2009-02-27
AP1071A (en)	2002-05-20
ZA986203B (en)	1999-08-18
UA66364C2 (uk)	2004-05-17
EA002883B1 (ru)	2002-10-31
NO324508B1 (no)	2007-11-05
CA2296742A1 (fr)	1999-01-28
DE69814395T2 (de)	2003-12-11
EP0998470A1 (de)	2000-05-10
SK284168B6 (sk)	2004-10-05
BR9810896A (pt)	2000-09-26
AR015924A1 (es)	2001-05-30
KR100519691B1 (ko)	2005-10-13
FR2766188A1 (fr)	1999-01-22
JP2001510191A (ja)	2001-07-31
DK0998470T3 (da)	2003-09-01
BG104073A (en)	2001-05-31
EA200000127A1 (ru)	2000-08-28
BG64050B1 (bg)	2003-11-28
IL134031A (en)	2004-06-01
FR2766188B1 (fr)	2000-02-11
CA2296742C (fr)	2009-12-08
HU230148B1 (hu)	2015-09-28
WO1999003852A1 (fr)	1999-01-28
YU1500A (sh)	2002-10-18
HRP20000027B1 (en)	2006-07-31
HUP0003857A2 (hu)	2001-04-28
TR200000117T2 (tr)	2000-07-21
ME01708B (me)	2008-08-07
SK302000A3 (en)	2000-11-07
NO20000182D0 (no)	2000-01-14
ID23784A (id)	2000-05-11
CN1269795A (zh)	2000-10-11
EP0998470B1 (de)	2003-05-07
AU744272B2 (en)	2002-02-21
IL134031A0 (en)	2001-04-30

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2004-12-15	GB1A	Change in the ownership or in the address of the owner
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231

Publication	Publication Date	Title
DE69908230D1 (de)	2003-07-03	Verfahren zum Herstellen von Alpha-Hydroxycarboxylaten
EP1023250A4 (de)	2001-03-21	Verfahren zur herstellung von 2,6-dialkylnaphthalin
DK0946531T3 (da)	2006-02-13	Fremgangsmåde til fremstilling af thiazol-derivater
NO993949L (no)	1999-09-07	FremgangsmÕte for fremstilling av substituert tiazolidindion
EE200000024A (et)	2000-10-16	Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
DK0975594T3 (da)	2002-10-14	Fremgangsmåde til fremstilling af indolderivater
DK0946514T3 (da)	2003-08-25	Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
NO20003454D0 (no)	2000-07-04	FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
TR199800403A3 (tr)	1998-09-21	a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
DK1075473T3 (da)	2007-11-05	Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
FI933755A7 (fi)	1993-08-26	Menetelmä trans-piperidiini-2,5-dikarboksylaattien valmistamiseksi
EE200000537A (et)	2001-06-15	Pürasolo[4,3-d]pürimidiin-7-oon-3-püridüülsulfonüülühendite ja nende vaheühendite valmistamise protsess
FI964410A7 (fi)	1996-11-01	Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
NO20020308D0 (no)	2002-01-21	Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
FI964429A7 (fi)	1996-11-04	Menetelmä 1-(3-trialkyylisilyylifenyyli)-2,2,2-trifluorimetyylietanoni n johdannaisten valmistamiseksi
NO900969D0 (no)	1990-03-01	Fremgangsmaate for fremstilling av anilin-derivat.
DK1202949T3 (da)	2004-07-19	Fremgangsmåde til fremstilling af acylerede 1,3-dicarbonylforbindelser
FI952287A7 (fi)	1995-11-14	Menetelmä 2-amino-4,6-dikloori-pyrimidiinin valmistamiseksi
IL138843A0 (en)	2001-10-31	Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
EE200000369A (et)	2001-12-17	Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
FI945414A0 (fi)	1994-11-17	Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
NO20012811D0 (no)	2001-06-07	Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
DK1080076T3 (da)	2004-03-22	Forbedret fremgangsmåde til fremstilling af farmaceutisk værdifulde norbenzomorphanderivater
FI971964A7 (fi)	1997-05-07	Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmista miseksi
NO20013044L (no)	2001-08-20	Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater